Tim Gill is a Colorado native, entrepreneur, and activist for
positive social change who actively supports equal rights and opportunity
for every citizen. He works to counter discrimination based on sexual
orientation and gender expression and his foundation has been a major factor in
advancing equality and human rights for the LGBT community across the nation. A
recipient of the University of Colorado Distinguished Service Award in 1996,
Gill endowed the Tim Gill Professorship in Infectious Diseases in 1998.
The Professorship was established to support HIV research at the
University of Colorado and to promote HIV education at the University and
within the Colorado community. This Professorship is
currently held by Division Head Dr. Eric Poeschla, who leads an NIH-funded
research program that investigates the processes by which HIV and other viruses
replicate, affect the immune system, and are countered by the immune system.
Each year a Tim Gill Distinguished Lecturer is
selected based on expertise in HIV research and care, for their skill in
teaching and for their humanism that informs and enhances their communities and
Past Tim Gill Distinguished Lectureships
September 14, 2016
Robert Grant, MD MPH
Senior Investigator, Gladstone Institutes
Professor of Medicine, University of California San Francisco
Chief Medical Officer, San Francisco AIDS Foundation
“Scaling up PrEP for impact”
August 26, 2015
Paula Cannon, Ph.D.
Associate Professor of Molecular Microbiology & Immunology
Keck School of Medicine, University of Southern California.
“Could Gene and Cell Therapies Cure HIV?”
May 14, 2014
Warner C. Greene, MD PhD
Gladstone Institute of Virology and Immunology
and Sue Hellmann Distinguished Professor of Translational Medicine
Professor of Medicine, Microbiology and Immunology
University of California, San Francisco
Executive Chairman, Accordia Global Health Foundation
"How HIV Causes AIDS: How Do CD4 T-Cells Die?"
April 10, 2013
David Margolis, MD
Professor of Medicine, Microbiology & Immunology, Epidemiology
University of North Carolina at Chapel Hill
"Assembling the Tools to Clear HIV Infection: Contributions from Virology and Immunology"
April 9, 2012
Kenneth E. Sherman, MD PhD
Professor, Division Director
Division of Digestive Diseases
University of Cincinnatti College of Medicine
March 8, 2011
Paul A. Volberding, MD
Professor and Vice Chair, UCSF Department of Medicine. Chief, Medical Services SF Veterans Affairs Medical Center. Co-Director, UCSF-GIVI Center for AIDS Research
"The Ongoing Relationship Between HIV and Cancer"
March 31, 2010
Carlos del Rio, MD
Professor and Chair
Hubert Department of Global Health at the Rollins School of Public Health and
Co-Director for the Clinical Science and International Research Core of the Emory
Center for AIDS Research
"Challenges for Providing HIV Care to Hard-to-Reach Populations in the US"
May 27, 2009
Gerald Friedland, M.D.
Professor of Medicine, Epidemiology and Public Health
Director, Yale AIDS Program Yale University
"Confronting HIV and XDR (Extremely Drug Resistant) TB in South Africa"
March 26, 2008
Kenneth Mayer, M.D.
Professor of Medicine and Community Health
Director, Brown University AIDS Program
“Biological Interventions to Prevent HIV: Pitfalls and Promise”
May 16, 2007
Judith S. Currier, M.D.
Professor of Medicine,
UCLA Center for AIDS Research and Education
Co-Director, CARE Center
“HIV in Women in America”
May 3, 2006
Wafaa El-Sadr, M.D.
Professor of Medicine and Epidemiology, Columbia University
Chief, Division of Infectious Diseases, Harlem Hospital Center
“The HIV Epidemic: Can it Transform the Health Care System Globally?”
March 4, 2002
Roberto Badaro, MD
Salvador, Bahia Brazil
“HIV in Brazil: The Intersection of the HIV Epidemic and Tropical Diseases”
May 17, 2000
Samuel A. Bozzette, MD, PhD
Senior Natural Scientist, RAND
Professor of Medicine, University of California, San Diego
“HIV Healthcare Treatment in the United States”
March 31, 1999
Bruce D. Walker, MD
Professor of Medicine, Harvard Medical School Massachusetts General Hospital, Boston
“Host Factors in the Control of HIV-1 Infection”
* State-of-the Art HIV-1 Research Laboratory. The Gill Foundation also helped the construction of one Laboratory.